Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Gains from Sales and Divestitures (2020)

Historic Gains from Sales and Divestitures for Selectis Health (GBCS) over the last 1 years, with Q4 2020 value amounting to $7500.0.

  • Selectis Health's Gains from Sales and Divestitures changed N/A to $7500.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $7500.0, marking a year-over-year change of. This contributed to the annual value of $7500.0 for FY2020, which is N/A changed from last year.
  • Selectis Health's Gains from Sales and Divestitures amounted to $7500.0 in Q4 2020.
  • Selectis Health's Gains from Sales and Divestitures' 5-year high stood at $7500.0 during Q4 2020, with a 5-year trough of $7500.0 in Q4 2020.